Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29:
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;
10.1016/j.aohep.2024.101774
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;
10.1016/j.aohep.2025.102176